CliffBio
small molecule

TRANDATE

LABETALOL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanySEBELA IRELAND LTD

Drug detail

Brand nameTRANDATE
Active ingredientLABETALOL HYDROCHLORIDE
Strength5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1985
Marketing statusDISCN

More from SEBELA IRELAND LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

TRANDATE patent cliff — loss of exclusivity — | CliffBio